CDYL2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10001764
Fusion event
HBV-CDYL2 integration
Validated
No
Detection method
HIVID
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
27703150
Virus Sequence
Virus name
HBV
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
Host Sequence
Chromosome
chr16
Cytoband
q23.2
Reference genome
GRCh37/hg19
Start
80826756/80792859 (Hg38)
End
80826756/80792859 (Hg38)
Location type
Intronic
Fragile sites / regions
FRA16D
Target gene
CDYL2
Nearest miRNA
hsa-mir-1225/Upstream/3923840; hsa-mir-11401/Downstream/592159;
Nearest TSS
ENST00000527434/Upstream/56499; ENST00000568445/Downstream/11404;
Nearest CpG islands
None/Target, chr16-CpG: 29/Upstream/251666, chr16-CpG: 180/Downstream/10568
Upstream sequence
gctaggaatatcgctgctgtgctgccaaaagctcacagatgtgtccctcaaagggaactgccctctgccacaggtaactactccgcccaagtctataccc
Downstream sequence
cttcccatggaacagcctaccagcaatgactggccgacgctgggatataagggcccagttcccttgcctcaatatgggacatttctgaagggccattaca
Reference
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.
Curate